Ken Griffin Tactile Systems Technology Inc Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$11.13 - $15.8 $36,729 - $52,140	-3,300 Reduced 20.37%	12,900 $154,000
Q1 2024 May 15, 2024	SELL	$13.63 - $16.75 $238,525 - $293,125	-17,500 Reduced 51.93%	16,200 $263,000
Q4 2023 Feb 14, 2024	SELL	$9.95 - $14.73 $307,455 - $455,157	-30,900 Reduced 47.83%	33,700 $481,000
Q3 2023 Nov 14, 2023	BUY	$12.95 - $25.63 $634,550 - $1.26 Million	49,000 Added 314.1%	64,600 $907,000
Q2 2023 Aug 14, 2023	BUY	$16.36 - $24.93 $26,176 - $39,888	1,600 Added 11.43%	15,600 $388,000
Q1 2023 May 15, 2023	BUY	$11.85 - $16.7 $165,900 - $233,800	14,000 New	14,000 $229,000

133

22.2M

12.9K

3.4K

Ticker TCMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,132,100
Market Cap $279M
Description
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for th...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.